We demonstrated that HOXB7 enhances proliferation, migration, and invasion of HCC cells through bFGF-induced MAPK/ERK pathway activation, and its expression was strongly associated with tumor recurrence and poor prognosis of HCC patients after surgery. Here, HOXB7 is linked to hepatocellular carcinoma.